[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editor's Correspondence
May 22, 2000

Overestimation of the Number of Individuals With Hypertension Who Are Eligible for Treatment According to the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure—Reply

Arch Intern Med. 2000;160(10):1537-1538. doi:

In reply

We are uncertain as to how Klungel and colleagues derived the information that 13.5% of our study subjects in the high-normal or hypertensive categories were eligible for initial drug therapy. As stated in our article,1 we calculated that 60.6% of these subjects were eligible for initial drug therapy or were already receiving drug therapy. If we consider only untreated subjects, 476 (32.0%) of 1488 fell into one of the following categories for which the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI) recommends initial drug therapy: (1) stage 2 or stage 3 hypertension, (2) stage 1 hypertension in risk group C, or (3) high-normal blood pressure with congestive heart failure or diabetes. These 476 subjects represent 17.0% of all 2794 subjects (treated and untreated with high-normal blood pressure or hypertension).

First Page Preview View Large
First page PDF preview
First page PDF preview
×